SPONSOR
Centre Hospitalier Universitaire de Saint Etienne
Total Trials
12
Recruiting
12
Phases
Phase 3, Phase 4
Conditions studied: Anti-MAG NeuropathySchizoaffective DisorderCancerChronic Neuropathic PainSpinal AmyotrophyInfantile Spinal Muscular AtrophyJuvenile Spinal Muscular AtrophyConstitutional ThinnessAcute Coronary SyndromeProstate Cancer
Centre Hospitalier Universitaire de Saint Etienne is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Anti-MAG Neuropathy, Schizoaffective Disorder, Cancer, Chronic Neuropathic Pain.
The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre Hospitalier Universitaire de Saint Etienne
How many clinical trials has Centre Hospitalier Universitaire de Saint Etienne sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Centre Hospitalier Universitaire de Saint Etienne, of which 12 are actively recruiting participants. These trials cover conditions including Anti-MAG Neuropathy, Schizoaffective Disorder, Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre Hospitalier Universitaire de Saint Etienne research focus on?
Centre Hospitalier Universitaire de Saint Etienne clinical trials span Anti-MAG Neuropathy, Schizoaffective Disorder, Cancer, Chronic Neuropathic Pain, Spinal Amyotrophy, and additional conditions. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Centre Hospitalier Universitaire de Saint Etienne clinical trial?
To participate in a Centre Hospitalier Universitaire de Saint Etienne trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Hospitalier Universitaire de Saint Etienne trials with current recruitment status updated daily.
Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne
NCT05136976 Phase 3
Recruiting
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
Anti-MAG Neuropathy
NCT07058389
Recruiting
Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.
Schizoaffective Disorder
NCT07187219
Recruiting
Efficacy of Repetitive Transcranial Magnetic Stimulation Over the Primary Cortex in Patients With Neuropathic Pain and Cancer
Cancer
NCT06562283
Recruiting
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
Spinal Amyotrophy
NCT06894043
Recruiting
Effect of an Intervention Program of Adapted Physical Activity Combined With Compensatory Nutrition in Patients With Constitutional Thinness
Constitutional Thinness
NCT06107452
Recruiting
Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability
Acute Coronary Syndrome
NCT05739565
Recruiting
Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients
Prostate Cancer
NCT06822907 Phase 4
Recruiting
Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults
Acute Febrile Illness
NCT06170645
Recruiting
Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue
Chronic Fatigue Syndrome
NCT06706102 Phase 4
Recruiting
Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome
Immune Effector Cell Associated Neurotoxicity Syndrome
NCT04374175
Recruiting
SERum-bank for PANcreatic Cancer
Adenocarcinoma
NCT06201026
Recruiting
Effects of Individualized Training to Reduce Fatigue in Patients With Newly and Advanced Diagnosed Multiple Sclerosis
Sclerosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology